252 related articles for article (PubMed ID: 38539424)
1. The Lipidomic Signature of Glioblastoma: A Promising Frontier in Cancer Research.
Yu N; Aboud O
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539424
[TBL] [Abstract][Full Text] [Related]
2. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.
Farrell C; Shi W; Bodman A; Olson JJ
J Neurooncol; 2020 Nov; 150(2):269-359. PubMed ID: 33215345
[TBL] [Abstract][Full Text] [Related]
3. Lipidomic analysis and diagnosis of glioblastoma multiforme with rapid evaporative ionization mass spectrometry.
Ma J; Li T; Chen H; Wang C; Wang H; Li Q
Electrophoresis; 2021 Oct; 42(19):1965-1973. PubMed ID: 34272893
[TBL] [Abstract][Full Text] [Related]
4. Anti-epidermal growth factor receptor therapy for glioblastoma in adults.
Lee A; Arasaratnam M; Chan DLH; Khasraw M; Howell VM; Wheeler H
Cochrane Database Syst Rev; 2020 May; 5(5):CD013238. PubMed ID: 32395825
[TBL] [Abstract][Full Text] [Related]
5. Clinical lipidomics in understanding of lung cancer: Opportunity and challenge.
Zhang L; Zhu B; Zeng Y; Shen H; Zhang J; Wang X
Cancer Lett; 2020 Feb; 470():75-83. PubMed ID: 31655086
[TBL] [Abstract][Full Text] [Related]
6. Investigating the Potential of Lipids for Use as Biomarkers for Glioblastoma via an Untargeted Lipidomics Approach.
Soylemez B; Bulut Z; Şahin-Bölükbaşı S
J Korean Neurosurg Soc; 2023 Mar; 66(2):133-143. PubMed ID: 36530132
[TBL] [Abstract][Full Text] [Related]
7. Determining and interpreting correlations in lipidomic networks found in glioblastoma cells.
Görke R; Meyer-Bäse A; Wagner D; He H; Emmett MR; Conrad CA
BMC Syst Biol; 2010 Sep; 4():126. PubMed ID: 20819237
[TBL] [Abstract][Full Text] [Related]
8. Advanced Magnetic Resonance Imaging in Pediatric Glioblastomas.
Gonçalves FG; Viaene AN; Vossough A
Front Neurol; 2021; 12():733323. PubMed ID: 34858308
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant immune checkpoint inhibition in the management of glioblastoma: Exploring a new frontier.
Frederico SC; Darling C; Bielanin JP; Dubinsky AC; Zhang X; Hadjipanayis CG; Kohanbash G
Front Immunol; 2023; 14():1057567. PubMed ID: 36875096
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?
Tanaka S; Louis DN; Curry WT; Batchelor TT; Dietrich J
Nat Rev Clin Oncol; 2013 Jan; 10(1):14-26. PubMed ID: 23183634
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts.
Franceschi E; Minichillo S; Brandes AA
CNS Drugs; 2017 Aug; 31(8):675-684. PubMed ID: 28681349
[TBL] [Abstract][Full Text] [Related]
12. Molecular advances of brain tumors in radiation oncology.
Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
[TBL] [Abstract][Full Text] [Related]
13. [Glioblastomas: clinical study and search for prognostic factors].
Mineo JF; Quintin-Roue I; Lucas B; Buburusan V; Besson G
Neurochirurgie; 2002 Dec; 48(6):500-9. PubMed ID: 12595806
[TBL] [Abstract][Full Text] [Related]
14. The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes.
Rehman AA; Elmore KB; Mattei TA
Neurosurg Focus; 2015 Mar; 38(3):E14. PubMed ID: 25727223
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic therapy for high-grade glioma.
Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
[TBL] [Abstract][Full Text] [Related]
16. Lipidomics in autoimmune diseases with main focus on systemic lupus erythematosus.
Ferreira HB; Pereira AM; Melo T; Paiva A; Domingues MR
J Pharm Biomed Anal; 2019 Sep; 174():386-395. PubMed ID: 31207360
[TBL] [Abstract][Full Text] [Related]
17. Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection.
Ringel F; Pape H; Sabel M; Krex D; Bock HC; Misch M; Weyerbrock A; Westermaier T; Senft C; Schucht P; Meyer B; Simon M;
Neuro Oncol; 2016 Jan; 18(1):96-104. PubMed ID: 26243790
[TBL] [Abstract][Full Text] [Related]
18. Lipidomics signature in post-COVID patient sera and its influence on the prolonged inflammatory response.
Garrido PF; Castillo-Peinado LS; Priego-Capote F; Barrio I; Piñeiro Á; Domínguez-Santalla MJ; Rodríguez-Ruiz E; Garcia-Fandino R
J Infect Public Health; 2024 Apr; 17(4):588-600. PubMed ID: 38368647
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme.
Aldoghachi AF; Aldoghachi AF; Breyne K; Ling KH; Cheah PS
Neuroscience; 2022 May; 491():240-270. PubMed ID: 35395355
[TBL] [Abstract][Full Text] [Related]
20. The prognosis of glioblastoma: a large, multifactorial study.
Luo C; Song K; Wu S; Hameed NUF; Kudulaiti N; Xu H; Qin ZY; Wu JS
Br J Neurosurg; 2021 Oct; 35(5):555-561. PubMed ID: 34236262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
